세계의 체외진단(IVD) 시약 시장 : 업계 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

IVD Reagents Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

US $ 4,995 ￦ 7,216,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,539,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,273,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

세계 체외진단(IVD) 시약 시장 규모는 2025년에 774억 달러, 2032년에는 1,195억 달러에 달할 것으로 예측되고 있습니다. 2025년-2032년 예측 기간에 6.4%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

체외진단(IVD) 시약은 진단 검사에 사용되는 중요한 구성 요소이며 다양한 질병의 검출, 모니터링 및 치료를 촉진합니다. 이 시약은 임상 실험실, 병원, 연구 기관에서 전염병 검사에서 종양학 및 유전자 검사에 이르기까지 광범위하게 사용됩니다. 맞춤형 의료가 중시되게 되어, 만성 질환의 유병률이 상승해, 포인트 오브 케어 검사 수요가 높아지고 있는 것이, 시장을 견인하는 주된 요인이 되고 있습니다. 분자진단이나 면역검정 등 진단기술의 진보가 체외진단 의약품 수요를 더욱 끌어 올리고 있습니다.

세계 체외진단(IVD) 시약 시장은 감염, 암, 당뇨병 등의 만성 질환, 질병의 조기 발견의 필요성 등 여러 요인에 의해 견인되고 있습니다. 차세대 시퀀싱(NGS)과 중합효소 연쇄반응(PCR)과 같은 고급 진단 기술의 채택은 고품질 시약에 대한 수요를 가속화하고 있습니다. 게다가, 특히 신흥국에서의 건강 관리 인프라의 확충은 진단 서비스에 대한 액세스 확대를 촉진하고 있습니다. 질병의 조기 진단을 촉진하는 정부의 이니셔티브와 의료비 증가도 시장 성장에 기여하고 있습니다.

유망한 성장이 예상되지만, 체외 진단 의약품 시장은 엄격한 규제 요건과 고급 진단 검사에 따른 고비용 등의 과제에 직면하고 있습니다. 새로운 시약의 규제 승인 복잡성은 시장 진입을 지연시키고 혁신적인 솔루션 개발에 영향을 줄 수 있습니다. 또한 검사 결과의 재현성과 정확성에 대한 우려가 시장 도입을 방해할 수 있습니다. 특히 자원이 한정된 환경에서는 특수 시약의 고가의 비용이 보급의 장벽이 되고, 지역에 따라서는 시장 확대가 제한됩니다.

체외진단(IVD) 시약 시장은 진단 기술의 지속적인 진보와 의료 연구에 대한 투자 증가로 큰 성장 기회를 제공합니다. 디지털 진단과 AI 주도형 진단의 대두는 검사의 효율과 정밀도를 높여 시장 참가자에게 새로운 길을 열 것으로 기대됩니다. 또한 재택 검사 키트와 자기 검사 키트의 동향이 높아짐에도 새로운 수익원을 개척하고 있습니다. 또한, 신흥국 시장에 맞는 비용 효율적인 솔루션 개발을 위한 시약 제조업체와 의료 제공업체와의 제휴는 유리한 기회를 제공합니다. 정밀의료에 있어서의 동반진단의 응용 확대도 성장의 열쇠가 되는 분야입니다.

이 보고서는 세계체외진단(IVD) 시약 시장을 조사했으며, 시약 유형별, 기술별, 용도별, 최종 이용 산업별, 지역별 동향 및 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장의 범위와 정의
• 시장 역학
• 거시경제 요인
• COVID-19의 영향 분석
• 예측 요인- 관련성과 영향

제3장 부가가치 통찰

제4장 세계 체외진단(IVD) 시약 시장 전망

• 주요 하이라이트
• 시장 규모의 분석과 예측
  • 과거 시장 규모 분석, 2019년-2024년
  • 현재 시장 규모 분석과 예측, 2025년-2032년
• 세계 체외진단(IVD) 시약 시장 전망 : 시약 유형별
  • 소개, 주요 조사 결과
  • 과거 시장 규모 분석, 시약 유형별, 2019년-2024년
  • 현재 시장 규모 분석과 예측, 시약 유형별, 2025년-2032년
  • 시장의 매력 분석 : 시약 유형별
• 세계 체외진단(IVD) 시약 시장 전망 : 기술별
  • 소개, 주요 조사 결과
  • 과거 시장 규모 분석, 기술별, 2019년-2024년
  • 현재 시장 규모 분석과 예측, 기술별, 2025년-2032년
  • 시장의 매력 분석 : 기술별
• 세계 체외진단(IVD) 시약 시장 전망 : 용도별
  • 소개, 주요 조사 결과
  • 과거 시장 규모 분석, 용도별, 2019년-2024년
  • 현재 시장 규모 분석과 예측, 용도별, 2025년-2032년
  • 시장의 매력 분석 : 용도별
• 세계 체외진단(IVD) 시약 시장 전망 : 최종 이용 산업별
  • 소개, 주요 조사 결과
  • 과거 시장 규모 분석, 최종 이용 산업별, 2019년-2024년
  • 현재 시장 규모 분석과 예측, 최종 이용 산업별, 2025년-2032년
  • 시장의 매력 분석 : 최종 이용 산업별

제5장 세계 체외진단(IVD) 시약 시장 전망 : 지역별

• 주요 하이라이트
• 과거 시장 규모 분석, 지역업별, 2019년-2024년
• 현재 시장 규모 분석과 예측, 지역별, 2025년-2032년
  • 북미
  • 유럽
  • 동아시아
  • 남아시아와 오세아니아
  • 라틴아메리카
  • 중동 및 아프리카
• 시장의 매력 분석 : 지역별

제6장 북미의 체외진단(IVD) 시약 시장 전망

제7장 유럽 체외진단(IVD) 시약 시장 전망

제8장 동아시아의 체외진단(IVD) 시약 시장 전망

제9장 남아시아 및 오세아니아의 체외진단(IVD) 시약 시장 전망

제10장 라틴아메리카 체외진단(IVD) 시약 시장 전망

제11장 중동 및 아프리카의 체외진단(IVD) 시약 시장 전망

제12장 경쟁 구도

• 시장 점유율 분석, 2025년
• 시장 구조
• 기업 프로파일(상세 - 개요, 재무, 전략, 최근 동향)
  • Abbott
  • Michelin
  • Agilent Technologies
  • Becton Dickinson
  • BioMerieux
  • Bio-Rad
  • Danaher
  • DiaSorin
  • Roche
  • Seegene
  • Sysmex
  • Thermo Fisher Scientific
  • Siemens Helthineers
  • Transasia Bio-Medicals Ltd.
  • Beacon Diagnostics Pvt. Ltd.
  • 기타

제13장 부록

SHW

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for IVD Reagents. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global IVD Reagents market from 2025 to 2032.

Key Insights:

• IVD Reagents Market Size (2025E): US$ 77.4 Bn
• Market Value Forecast (2032F): US$ 119.5 Bn
• Projected Growth (CAGR 2025 to 2032): 6.4%

IVD Reagents Market - Report Scope:

IVD (In Vitro Diagnostics) reagents are essential components used in diagnostic testing, facilitating the detection, monitoring, and treatment of various diseases. These reagents are widely used in clinical laboratories, hospitals, and research institutions for applications ranging from infectious disease testing to oncology and genetic testing. The growing emphasis on personalized medicine, increased prevalence of chronic diseases, and rising demand for point-of-care testing are key factors driving the market. Technological advancements in diagnostic techniques, such as molecular diagnostics and immunoassays, are further fueling the demand for IVD reagents.

Market Growth Drivers:

The global IVD reagents market is driven by several factors, including the rising burden of infectious diseases, chronic conditions such as cancer and diabetes, and the need for early disease detection. The adoption of advanced diagnostic technologies, such as next-generation sequencing (NGS) and polymerase chain reaction (PCR), is accelerating the demand for high-quality reagents. Additionally, the expansion of healthcare infrastructure, particularly in emerging economies, is facilitating greater access to diagnostic services. Government initiatives promoting early disease diagnosis and increased healthcare expenditure are also contributing to market growth.

Market Restraints:

Despite promising growth prospects, the IVD reagents market faces challenges such as stringent regulatory requirements and high costs associated with advanced diagnostic testing. The complexity of regulatory approvals for new reagents can delay market entry, impacting the development of innovative solutions. Additionally, concerns regarding the reproducibility and accuracy of test results may hinder market adoption. The high costs of specialized reagents, particularly in resource-limited settings, pose a barrier to widespread use, limiting market expansion in some regions.

Market Opportunities:

The IVD reagents market presents significant growth opportunities driven by ongoing advancements in diagnostic technologies and increasing investment in healthcare research. The rise of digital and AI-driven diagnostics is expected to enhance the efficiency and accuracy of testing, creating new avenues for market players. The growing trend of at-home and self-testing kits is also opening new revenue streams. Additionally, partnerships between reagent manufacturers and healthcare providers for the development of cost-effective solutions tailored to emerging markets offer lucrative opportunities. The increasing application of companion diagnostics in precision medicine is another key area of growth.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the IVD reagents market globally?
• How do advancements in molecular diagnostics impact the demand for IVD reagents?
• Which diagnostic segments are experiencing the highest growth within the market?
• Who are the key players in the IVD reagents market, and what strategies are they employing to maintain competitiveness?
• What are the emerging trends and future growth prospects in the global IVD reagents market?

Competitive Intelligence and Business Strategy:

Leading players in the global IVD reagents market, including Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Danaher Corporation, and Bio-Rad Laboratories, are focusing on research and development, strategic partnerships, and product innovation to strengthen their market position. Companies are investing in automation and digital healthcare solutions to enhance diagnostic capabilities. Collaborations with biotech firms and research institutions for the development of novel reagents are also a key strategy. The expansion of product portfolios through mergers and acquisitions is further shaping the competitive landscape of the market.

Key Companies Profiled:

• Abbott
• Agilent Technologies
• Becton Dickinson
• bioMerieux
• Bio-Rad
• Danaher
• DiaSorin
• Roche
• Seegene
• Sysmex
• Thermo Fisher Scientific
• Siemens Healthineers
• Transasia Bio-Medicals Ltd.
• Beacon Diagnostics Pvt. Ltd.

IVD Reagents Market Segmentation

By Type of Reagent

• Antibodies
• Antigens
• Oligonucleotides
• Enzymes
• Nucleic Acid Probes

By Technology

• Immunoassay
• Molecular Diagnostics
• Clinical Chemistry
• Hematology
• Microbiology

By Application

• Infectious Diseases
• Cancer/Oncology
• Cardiology
• Autoimmune Diseases
• Genetic Testing
• Neurology

By End-Use Industry

• Hospitals
• Clinical Laboratories
• Point-of-Care Testing Facilities
• Home Care Settings

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• The Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global IVD Reagents Market Snapshot, 2025-2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Regulatory Landscape
• 3.2. Application Epidemiology
• 3.3. Pipeline Analysis
• 3.4. Product Adoption Analysis
• 3.5. Value Chain Analysis
• 3.6. Key Promotional Strategies by Manufacturers
• 3.7. PESTLE Analysis
• 3.8. Porter's Five Force Analysis

4. Global IVD Reagents Market Outlook:

• 4.1. Key Highlights
  • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
  • 4.1.2. Absolute $ Opportunity
• 4.2. Market Size (US$ Bn) Analysis and Forecast
  • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
  • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
• 4.3. Global IVD Reagents Market Outlook: Type of Reagent
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Type of Reagent, 2019-2024
  • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 4.3.3.1. Antibodies
    • 4.3.3.2. Antigens
    • 4.3.3.3. Oligonucleotides
    • 4.3.3.4. Enzymes
    • 4.3.3.5. Nucleic Acid Probes
    • 4.3.3.6. Others
  • 4.3.4. Market Attractiveness Analysis: Type of Reagent
• 4.4. Global IVD Reagents Market Outlook: Technology
  • 4.4.1. Introduction / Key Findings
  • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Technology, 2019-2024
  • 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 4.4.3.1. Immunoassay
    • 4.4.3.2. Molecular Diagnostics
    • 4.4.3.3. Clinical Chemistry
    • 4.4.3.4. Hematology
    • 4.4.3.5. Microbiology
    • 4.4.3.6. Others
  • 4.4.4. Market Attractiveness Analysis: Technology
• 4.5. Global IVD Reagents Market Outlook: Application
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
  • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 4.5.3.1. Infectious Diseases
    • 4.5.3.2. Cancer/Oncology
    • 4.5.3.3. Cardiology
    • 4.5.3.4. Autoimmune Diseases
    • 4.5.3.5. Genetic Testing
    • 4.5.3.6. Neurology
    • 4.5.3.7. Others
  • 4.5.4. Market Attractiveness Analysis: Application
• 4.6. Global IVD Reagents Market Outlook: End-Use Industry
  • 4.6.1. Introduction / Key Findings
  • 4.6.2. Historical Market Size (US$ Bn) Analysis, By End-Use Industry, 2019-2024
  • 4.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 4.6.3.1. Hospitals
    • 4.6.3.2. Point-Of-Care Testing Facilities
    • 4.6.3.3. Home Care Settings
    • 4.6.3.4. Others
  • 4.6.4. Market Attractiveness Analysis: End-Use Industry

5. Global IVD Reagents Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
• 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America IVD Reagents Market Outlook:

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 6.2.1. By Country
  • 6.2.2. By Type of Reagent
  • 6.2.3. By Technology
  • 6.2.4. By Application
  • 6.2.5. By Application
  • 6.2.6. By End-Use Industry
• 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
  • 6.4.1. Antibodies
  • 6.4.2. Antigens
  • 6.4.3. Oligonucleotides
  • 6.4.4. Enzymes
  • 6.4.5. Nucleic Acid Probes
  • 6.4.6. Others
• 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
  • 6.5.1. Immunoassay
  • 6.5.2. Molecular Diagnostics
  • 6.5.3. Clinical Chemistry
  • 6.5.4. Hematology
  • 6.5.5. Microbiology
  • 6.5.6. Others
• 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 6.6.1. Infectious Diseases
  • 6.6.2. Cancer/Oncology
  • 6.6.3. Cardiology
  • 6.6.4. Autoimmune Diseases
  • 6.6.5. Genetic Testing
  • 6.6.6. Neurology
  • 6.6.7. Others
• 6.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
  • 6.7.1. Hospitals
  • 6.7.2. Point-Of-Care Testing Facilities
  • 6.7.3. Home Care Settings
  • 6.7.4. Others
• 6.8. Market Attractiveness Analysis

7. Europe IVD Reagents Market Outlook:

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Type of Reagent
  • 7.2.3. By Technology
  • 7.2.4. By Application
  • 7.2.5. By Application
  • 7.2.6. By End-Use Industry
• 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Russia
  • 7.3.7. Turkey
  • 7.3.8. Rest of Europe
• 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
  • 7.4.1. Antibodies
  • 7.4.2. Antigens
  • 7.4.3. Oligonucleotides
  • 7.4.4. Enzymes
  • 7.4.5. Nucleic Acid Probes
  • 7.4.6. Others
• 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
  • 7.5.1. Immunoassay
  • 7.5.2. Molecular Diagnostics
  • 7.5.3. Clinical Chemistry
  • 7.5.4. Hematology
  • 7.5.5. Microbiology
  • 7.5.6. Others
• 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 7.6.1. Infectious Diseases
  • 7.6.2. Cancer/Oncology
  • 7.6.3. Cardiology
  • 7.6.4. Autoimmune Diseases
  • 7.6.5. Genetic Testing
  • 7.6.6. Neurology
  • 7.6.7. Others
• 7.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
  • 7.7.1. Hospitals
  • 7.7.2. Point-Of-Care Testing Facilities
  • 7.7.3. Home Care Settings
  • 7.7.4. Others
• 7.8. Market Attractiveness Analysis

8. East Asia IVD Reagents Market Outlook:

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Type of Reagent
  • 8.2.3. By Technology
  • 8.2.4. By Application
  • 8.2.5. By Application
  • 8.2.6. By End-Use Industry
• 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
• 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
  • 8.4.1. Antibodies
  • 8.4.2. Antigens
  • 8.4.3. Oligonucleotides
  • 8.4.4. Enzymes
  • 8.4.5. Nucleic Acid Probes
  • 8.4.6. Others
• 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
  • 8.5.1. Immunoassay
  • 8.5.2. Molecular Diagnostics
  • 8.5.3. Clinical Chemistry
  • 8.5.4. Hematology
  • 8.5.5. Microbiology
  • 8.5.6. Others
• 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 8.6.1. Infectious Diseases
  • 8.6.2. Cancer/Oncology
  • 8.6.3. Cardiology
  • 8.6.4. Autoimmune Diseases
  • 8.6.5. Genetic Testing
  • 8.6.6. Neurology
  • 8.6.7. Others
• 8.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
  • 8.7.1. Hospitals
  • 8.7.2. Point-Of-Care Testing Facilities
  • 8.7.3. Home Care Settings
  • 8.7.4. Others
• 8.8. Market Attractiveness Analysis

9. South Asia & Oceania IVD Reagents Market Outlook:

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Type of Reagent
  • 9.2.3. By Technology
  • 9.2.4. By Application
  • 9.2.5. By Application
  • 9.2.6. By End-Use Industry
• 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. India
  • 9.3.2. Southeast Asia
  • 9.3.3. ANZ
  • 9.3.4. Rest of South Asia & Oceania
• 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
  • 9.4.1. Antibodies
  • 9.4.2. Antigens
  • 9.4.3. Oligonucleotides
  • 9.4.4. Enzymes
  • 9.4.5. Nucleic Acid Probes
  • 9.4.6. Others
• 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
  • 9.5.1. Immunoassay
  • 9.5.2. Molecular Diagnostics
  • 9.5.3. Clinical Chemistry
  • 9.5.4. Hematology
  • 9.5.5. Microbiology
  • 9.5.6. Others
• 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 9.6.1. Infectious Diseases
  • 9.6.2. Cancer/Oncology
  • 9.6.3. Cardiology
  • 9.6.4. Autoimmune Diseases
  • 9.6.5. Genetic Testing
  • 9.6.6. Neurology
  • 9.6.7. Others
• 9.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
  • 9.7.1. Hospitals
  • 9.7.2. Point-Of-Care Testing Facilities
  • 9.7.3. Home Care Settings
  • 9.7.4. Others
• 9.8. Market Attractiveness Analysis

10. Latin America IVD Reagents Market Outlook:

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Type of Reagent
  • 10.2.3. By Technology
  • 10.2.4. By Application
  • 10.2.5. By Application
  • 10.2.6. By End-Use Industry
• 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. Brazil
  • 10.3.2. Mexico
  • 10.3.3. Rest of Latin America
• 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
  • 10.4.1. Antibodies
  • 10.4.2. Antigens
  • 10.4.3. Oligonucleotides
  • 10.4.4. Enzymes
  • 10.4.5. Nucleic Acid Probes
  • 10.4.6. Others
• 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
  • 10.5.1. Immunoassay
  • 10.5.2. Molecular Diagnostics
  • 10.5.3. Clinical Chemistry
  • 10.5.4. Hematology
  • 10.5.5. Microbiology
  • 10.5.6. Others
• 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 10.6.1. Infectious Diseases
  • 10.6.2. Cancer/Oncology
  • 10.6.3. Cardiology
  • 10.6.4. Autoimmune Diseases
  • 10.6.5. Genetic Testing
  • 10.6.6. Neurology
  • 10.6.7. Others
• 10.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
  • 10.7.1. Hospitals
  • 10.7.2. Point-Of-Care Testing Facilities
  • 10.7.3. Home Care Settings
  • 10.7.4. Others
• 10.8. Market Attractiveness Analysis

11. Middle East & Africa IVD Reagents Market Outlook:

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Type of Reagent
  • 11.2.3. By Technology
  • 11.2.4. By Application
  • 11.2.5. By Application
  • 11.2.6. By End-Use Industry
• 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. GCC Countries
  • 11.3.2. Egypt
  • 11.3.3. South Africa
  • 11.3.4. Northern Africa
  • 11.3.5. Rest of Middle East & Africa
• 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
  • 11.4.1. Antibodies
  • 11.4.2. Antigens
  • 11.4.3. Oligonucleotides
  • 11.4.4. Enzymes
  • 11.4.5. Nucleic Acid Probes
  • 11.4.6. Others
• 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
  • 11.5.1. Immunoassay
  • 11.5.2. Molecular Diagnostics
  • 11.5.3. Clinical Chemistry
  • 11.5.4. Hematology
  • 11.5.5. Microbiology
  • 11.5.6. Others
• 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 11.6.1. Infectious Diseases
  • 11.6.2. Cancer/Oncology
  • 11.6.3. Cardiology
  • 11.6.4. Autoimmune Diseases
  • 11.6.5. Genetic Testing
  • 11.6.6. Neurology
  • 11.6.7. Others
• 11.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
  • 11.7.1. Hospitals
  • 11.7.2. Point-Of-Care Testing Facilities
  • 11.7.3. Home Care Settings
  • 11.7.4. Others
• 11.8. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2025
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping By Market
  • 12.2.2. Competition Dashboard
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. Abbott
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Products
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. Michelin
  • 12.3.3. Agilent Technologies
  • 12.3.4. Becton Dickinson
  • 12.3.5. BioMerieux
  • 12.3.6. Bio-Rad
  • 12.3.7. Danaher
  • 12.3.8. DiaSorin
  • 12.3.9. Roche
  • 12.3.10. Seegene
  • 12.3.11. Sysmex
  • 12.3.12. Thermo Fisher Scientific
  • 12.3.13. Siemens Helthineers
  • 12.3.14. Transasia Bio-Medicals Ltd.
  • 12.3.15. Beacon Diagnostics Pvt. Ltd.
  • 12.3.16. Others

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations

관련자료